Pombiliti 105 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
7680678040015
CH-67804
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Associated product:
POMBILITI subst sèche 105 mg flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Ampulle(n)
- Galenic form
- Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
cipaglucosidasum alfa
|
105.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
natrium
|
10.5 MG | Substance | HBESI |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1096.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Amicus Therapeutics Switzerland GmbH
8008 Zürich
Authorization information
- Swissmedic authorization number
- 67804
- Drug name
- Pombiliti, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- A16AB23
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 04/07/2024
- Authorization expiration date
- 03/07/2029
- IT Number
- 07.14.0.
- Domain
- Human medicine
Package details
- Description (FR)
- POMBILITI subst sèche 105 mg flac
- Description (DE)
- POMBILITI Trockensub 105 mg Durchstf
- Market launch
- 04/07/2024
- Narcotic (BTM)
- No
Other package sizes (2)
POMBILITI subst seche 105 mg 10 pce
10 AMP
GTIN: 7680678040022
None
25 AMP
GTIN: None